Left Atrial Appendage Closure and Systemic Homeostasis: The LAA HOMEOSTASIS Study

https://www.ncbi.nlm.nih.gov/pubmed/29325636

Safety profiles of percutaneous left atrial appendage closure devices:  An analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE) database from 2009 to 2016.

https://onlinelibrary.wiley.com/action/doSearch?AllField=Safety+profiles+of+percutaneous+left+atrial+appendage+closure+devices%3A+an+analysis+of+the+food&SeriesKey=15408167

Lakkireddy D, Afzal MR, Lee RJ, et al. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: results from a US multicenter evaluation. Heart Rhythm. 2016;13(5):1030-1036.

http://www.ncbi.nlm.nih.gov/pubmed/26872554

Lakkireddy D, Mahankali AS, Kanmanthareddy A, et al. Left atrial appendage ligation and ablation for persistent atrial fibrillation (The LAALA-AF Registry). JACCCEP. 2015;1(3):153-160.

http://electrophysiology.onlinejacc.org/article.aspx?articleid=2299813

Pillarisetti J, Reddy YM, Gunda S, et al. Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications. Heart Rhythm. 2015;12(7):1501-1507.

http://www.ncbi.nlm.nih.gov/pubmed/25778430v

Lee RJ, Lakkireddy D, Mittal S, et al. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and design. Am Heart J. 2015;170(6):1184-1194.

http://www.ncbi.nlm.nih.gov/pubmed/26678640

Badhwar N, Lakkireddy D, Kawamura M, et al. Sequential percutaneous LAA ligation and pulmonary vein isolation in patients with persistent AF: initial results of a feasibility study. J Cardiovasc Electrophysiol.. 2015;26(6):608-614.

http://www.ncbi.nlm.nih.gov/pubmed/25772569

Afzal MR, Kanmanthareddy A, Earnest M, et al. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015;12(1):52-59.

http://www.ncbi.nlm.nih.gov/pubmed/25281005

Laura DM, Chinitz LA, Aizer A, et al. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device. J Am Soc Echocardiogr. 2014;27(7):699-708.

http://www.ncbi.nlm.nih.gov/pubmed/24874974

Han FT, Bartus K, Lakkireddy D, et al. The effects of LAA ligation on LAA electrical activity. Heart Rhythm. 2014;11(5):864-870.

http://www.ncbi.nlm.nih.gov/pubmed/24444443

Bartus K, Morelli RL, Szczepanski W, et al. Anatomic analysis of the left atrial appendage after closure with the LARIAT device. Circ Arrhythm Electrophysiol. 2014;7(4):764-767.

http://circep.ahajournals.org/content/7/4/764.extract

Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013;111(6):869-873.

http://www.ncbi.nlm.nih.gov/pubmed/23312129

Bartus K, Morelli RL, Szczepanski W, et al. Anatomic analysis of the left atrial appendage after closure with the LARIAT device. Circ Arrhythm Electrophysiol. 2014;7(4):764-767.

http://circep.ahajournals.org/content/7/4/764.extract

Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol. 2013;111(6):869-873.

http://www.ncbi.nlm.nih.gov/pubmed/23312129

Bartus K, Bednarek J, Myc J, et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm. 2011;8(2):188-193.

http://www.ncbi.nlm.nih.gov/pubmed/21050893

Stone D, Byrne T, Pershad A. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation. Catheter Cardiovasc Interv. 2015;86(1):121-127.

http://www.ncbi.nlm.nih.gov/pubmed/23765504

Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62(2):108-118.

http://www.ncbi.nlm.nih.gov/pubmed/23062528

Di Biase L, Burkhardt JD, Mohanty P, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109-118.

http://www.ncbi.nlm.nih.gov/pubmed/20606120

Hocini M, Shah AJ, Nault I, et al. Localized reentry within the left atrial appendage: arrhythmogenic role in patients undergoing ablation of persistent atrial fibrillation. Heart Rhythm. 2010:8(12):1853-1861.

http://www.ncbi.nlm.nih.gov/pubmed/21762673

Brooks AG, Stiles MK, Laborderie J, et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm. 2010;7:835-846.

http://www.ncbi.nlm.nih.gov/pubmed/20206320

Verma A, Mantovan R, Macie L, et al. Substrate and trigger ablation for reduction of atrial fibrillation trial-part II (STAR AF II): design and rationale. Eur Heart J. 2010;31(11):1344-1356.

http://www.ncbi.nlm.nih.gov/pubmed/20215126

Dixit S, Marchlinski FE, Lin D, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5(2):287-294.

http://www.ncbi.nlm.nih.gov/pubmed/22139886

Tilz RR, Rillig A, Thum AM, et al. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg sequential ablation strategy. J Am Coll Cardiol. 2012;60:1921-1929.

http://www.ncbi.nlm.nih.gov/pubmed/23062545

Elayi CS, Verma A, Di Biase L, et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study comparing three different strategies. Heart Rhythm. 2008;5:1658-1664.

http://www.ncbi.nlm.nih.gov/pubmed/19084800